Andrea Vismara
Net worth: 14 M $ as of 31/05/2026
Net worth: 14 M $ as of 31/05/2026
Andrea Vismara is Chief Executive Officer at Equita SIM SpA since 2017.
Mr. Vismara is Chief Executive Officer & Director at Equita Group SpA since 2008.
Mr. Vismara is Director at Blue Earth Diagnostics Ltd. Mr. Vismara is Director at Blue Earth Therapeutics Ltd. since 2022.
Mr. Vismara is Member at Commissione Nazionale per le Società e la Borsa.
Mr. Vismara is President at Equita Sim SpA (Investment Management) starting 2026.
Former roles include Vice Chairman at Assosim Associazione Italiana Intermediari Mobiliari and Chief Operating Officer at Credit Suisse First Boston Italia SpA from 2002 to 2003.
Education includes graduate degree from New York University and undergraduate degree from the University of Bocconi.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EQUITA GROUP SPA 3.94% | 31/07/2025 | 2,101,734 ( 3.94% ) | 14 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| EQUITA GROUP S.P.A. | Chief Executive Officer | - |
Equita SIM SpA
Equita SIM SpA Investment Banks/BrokersFinance Provides brokerage services | Chief Executive Officer | 01/07/2017 |
Equita Sim SpA (Investment Management)
Equita Sim SpA (Investment Management) Investment ManagersFinance Equita Sim-IM is mainly focused on alternative, illiquid strategies in the Italian market with a focus on mid and small-caps. | President | 01/01/2026 |
Commissione Nazionale per le Società e la Borsa
Commissione Nazionale per le Società e la Borsa General GovernmentGovernment Regulation of public savings | Corporate Officer/Principal | - |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Director/Board Member | - |
Blue Earth Therapeutics Ltd.
Blue Earth Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops radiopharmaceuticals and oncology drugs | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Credit Suisse First Boston Italia SpA
Credit Suisse First Boston Italia SpA Investment Banks/BrokersFinance Provides securities, investment banking, insurance, investment trust, and management services | Chief Operating Officer | 01/01/2003 |
Assosim Associazione Italiana Intermediari Mobiliari | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Equita SIM SpA
Equita SIM SpA Investment Banks/BrokersFinance Provides brokerage services | Finance |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Credit Suisse First Boston Italia SpA
Credit Suisse First Boston Italia SpA Investment Banks/BrokersFinance Provides securities, investment banking, insurance, investment trust, and management services | Finance |
Commissione Nazionale per le Società e la Borsa
Commissione Nazionale per le Società e la Borsa General GovernmentGovernment Regulation of public savings | Government |
Assosim Associazione Italiana Intermediari Mobiliari | |
Equita Sim SpA (Investment Management)
Equita Sim SpA (Investment Management) Investment ManagersFinance Equita Sim-IM is mainly focused on alternative, illiquid strategies in the Italian market with a focus on mid and small-caps. | Finance |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Health Services |
Equita Group SpA
Equita Group SpA Investment Banks/BrokersFinance Operates as holding company whose subsidiary provides investment banking services | Finance |
Blue Earth Therapeutics Ltd.
Blue Earth Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops radiopharmaceuticals and oncology drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions